Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Cirrhotic Patients: A Systematic Review and Meta-Analysis
Objective Currently, there is limited evidence regarding the use of direct oral anticoagulants (DOACs) for patients with liver cirrhosis (LC). We performed a meta-analysis to compare the efficacy and safety of DOACs versus warfarin in this population. Methods We searched PubMed, Cochrane Library, We...
Saved in:
| Main Authors: | Chunwei Cheng MD, Juan Hua MD, Liang Xiong MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296241301402 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review
by: Xiulin Xiao M.S., et al.
Published: (2024-11-01) -
Effectiveness and Safety of the Coadministration of Rifampin and Warfarin versus Direct Oral Anticoagulants: A Cohort Study
by: Ju-Chieh Wung, et al.
Published: (2024-01-01) -
The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic
by: Ubonwan Sapoo, et al.
Published: (2024-07-01) -
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
by: Sherif Elhosseiny, et al.
Published: (2019-01-01) -
Risk of mortality between warfarin and direct oral anticoagulants: population-based cohort studies
by: Zixuan Wang, et al.
Published: (2024-12-01)